arrow_back Back Filing freshness 10-K Q4 FY2025 SEC EDGAR

AiXin Life International, Inc.

AIXN
— Price unavailable
Healthcare ·Retail-Drug Stores and Proprietary Stores ·USRetail-Drug Stores and Proprietary Stores
68 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
52
Health
Fair
Neutral
auto_awesome

Analytical Summary

AiXin Life International, Inc. shows mixed fundamentals. However, watch Operating Margin (%) which shows concerning trends. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap —
Dividend Yield —
Revenue Growth -53.4% ↗
Op. Margin -207.6% ↘
ROIC 10.3% ↗
FCF / Share None
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity -0.01
info Valuation on last close.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$327.69K
↓ -53.4% —
Net Income Profit after all expenses
$-628.79K
↑ +56.4% —
Operating Margin Operating profit as % of sales
-207.6%
↓ -80.5% 1th
FCF / Share Free cash flow per share
$-0.02
↓ -31.2% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
2
Returns ↑
93
Financial Health ↓
56
Cash Quality ↑
66

bar_chart Data from SEC EDGAR XBRL filings

Synced 3 days ago 18 years · 68 quarters